A Multicenter, Double-Blind, Placebo and Active-Controlled, Dose-Finding Study of MK0974 in the Treatment of Acute Migraine

Trial Profile

A Multicenter, Double-Blind, Placebo and Active-Controlled, Dose-Finding Study of MK0974 in the Treatment of Acute Migraine

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Dec 2014

At a glance

  • Drugs Telcagepant (Primary) ; Rizatriptan
  • Indications Migraine; Migraine with aura; Migraine without aura
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 03 Aug 2008 Actual end date (May 2006) added as reported by ClinicalTrials.gov.
    • 03 Aug 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 03 Aug 2008 Official title added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top